Novavax, Inc. (NVAX) Initiated with a Buy at Citigroup

Shares of Novavax, Inc. (NVAX) are up almost 4% to $4.50 in pre-market trading Wednesday after the company was initiated with a ‘Buy’ rating at Citigroup (C). Currently there are 2 analysts that rate Novavax shares a ‘Strong Buy’ and 2 a ‘Buy’. No analysts rate it a ‘Sell’. The biopharmaceuticals company has a median […]


View the full post at: Novavax, Inc. (NVAX) Initiated with a Buy at Citigroup


Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks